The Pregenesys Consensus Meeting held in Cambridge on 13 July 2009 was organized by the Pregenesys Consortium to review and critically discuss current knowledge regarding early markers of preeclampsia, to identify priorities and opportunities for future research, to consider issues that may need to be addressed in future recommendations and to highlight key issues in cost effectiveness and national policies concerning prediction and early screening for the risk of developing preeclampsia. This report summarizes the outcome of the Consensus Meeting and draws attention to issues for further investigation with specific regard to single versus multiple markers, early versus late risk identification, and the long-term effects on both maternal and perinatal health and the need to include these in any future cost-benefit assessment.

Pregenesys pre-eclampsia markers consensus meeting : What do we require from markers, risk assessment and model systems to tailor preventive strategies ? / I. Cetin, B. Huppertz, G. Burton, H. Cuckle, R. Gonen, O. Lapaire, L. Mandia, K. Nicolaides, C. Redman, P. Soothill, K. Spencer, B. Thilaganathan, D. Williams, H. Meiri. - In: PLACENTA. - ISSN 0143-4004. - 32:Suppl.1(2011), pp. S4-S16.

Pregenesys pre-eclampsia markers consensus meeting : What do we require from markers, risk assessment and model systems to tailor preventive strategies ?

I. Cetin
Primo
;
L. Mandia;
2011

Abstract

The Pregenesys Consensus Meeting held in Cambridge on 13 July 2009 was organized by the Pregenesys Consortium to review and critically discuss current knowledge regarding early markers of preeclampsia, to identify priorities and opportunities for future research, to consider issues that may need to be addressed in future recommendations and to highlight key issues in cost effectiveness and national policies concerning prediction and early screening for the risk of developing preeclampsia. This report summarizes the outcome of the Consensus Meeting and draws attention to issues for further investigation with specific regard to single versus multiple markers, early versus late risk identification, and the long-term effects on both maternal and perinatal health and the need to include these in any future cost-benefit assessment.
Preeclampsia ; Placenta ; Endothelial damage ; Early diagnosis ; IUGR ; PP13 ; PAPP-A ; PIGF ; PTX3 ; Uterine Doppler ; Genomics and proteomics markers ;
Settore MED/40 - Ginecologia e Ostetricia
2011
Article (author)
File in questo prodotto:
File Dimensione Formato  
YPLAC2263.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 983.28 kB
Formato Adobe PDF
983.28 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/152152
Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 71
  • ???jsp.display-item.citation.isi??? 61
social impact